Pilot Study on the Role of Circulating miRNAs for the Improvement of the Predictive Ability of the 2MACE Score in Patients with Atrial Fibrillation

Journal of Clinical Medicine
José Miguel Rivera-CaravacaRocío González-Conejero

Abstract

Background. Atrial fibrillation (AF) increases the risk for stroke but also for non-stroke major adverse cardiovascular events (MACE). The 2MACE score was recently proposed to predict these events. Since the interest of microRNAs (miRNAs) in cardiovascular diseases is increasing, we aimed to investigate whether miRNA levels may improve the predictive performance of the 2MACE score. Methods. We included consecutive AF patients stable on vitamin K antagonist therapy. Blood samples were drawn at baseline and plasma expression of miRNAs was assessed. During a median of 7.6 (interquartile range (IQR) 5.4-8.0) years, the occurrence of any MACE (nonfatal myocardial infarction/cardiac revascularization and cardiovascular death) was recorded. Results. We conducted a miRNA expression analysis in plasma from 19 patients with and without cardiovascular events. The miRNAs selected (miR-22-3p, miR-107, and miR-146a-5p) were later measured in 166 patients (47% male, median age 77 (IQR 70-81) years) and all were associated with a higher risk of MACE. The addition of miR-107 and miR-146a-5p to the 2MACE score significantly increased the predictive performance (c-indexes: 0.759 vs. 0.694, p = 0.004), and the model with three miRNAs also improved...Continue Reading

References

Nov 14, 2006·Medical Decision Making : an International Journal of the Society for Medical Decision Making·Andrew J Vickers, Elena B Elkin
Jul 30, 2008·Proceedings of the National Academy of Sciences of the United States of America·Patrick S MitchellMuneesh Tewari
May 28, 2011·Journal of Cellular Physiology·Xu-Dong XuYong-Wen Qin
Nov 29, 2011·European Journal of Heart Failure·Yaron GorenOffer Amir
Mar 26, 2013·Circulation Research·Zhan-Peng HuangDa-Zhi Wang
Jul 11, 2014·Thrombosis and Haemostasis·Vanessa RoldánConstantino Martínez
Sep 15, 2014·Trends in Cardiovascular Medicine·Zhan-Peng Huang, Da-Zhi Wang
Jan 24, 2015·Environmental Health Perspectives·Karen VrijensTim S Nawrot
Oct 17, 2015·Internal and Emergency Medicine·Daniele PastoriFrancesco Violi
May 22, 2016·Journal of the American Heart Association·Francesco VioliDaniele Pastori
Jan 21, 2017·Circulation Research·Janika Viereck, Thomas Thum
Mar 30, 2017·BioMed Research International·Ananília Medeiros Gomes da SilvaVivian Nogueira Silbiger
Jul 20, 2017·Current Medicinal Chemistry·Adam IoannouDimitris Tousoulis
Sep 22, 2017·Current Medicinal Chemistry·Alexandros BriasoulisDimitris Tousoulis
Oct 8, 2017·International Journal of Cardiology·Marija PolovinaPetar M Seferović
Nov 8, 2017·The American Journal of Cardiology·José Miguel Rivera-CaravacaVanessa Roldán
Feb 14, 2018·Arteriosclerosis, Thrombosis, and Vascular Biology·Ana B ArroyoRocío González-Conejero
Mar 6, 2018·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Ida MannaAldo Quattrone
Oct 18, 2018·Annual Review of Pathology·Perry V HalushkaMarc K Halushka
Nov 6, 2018·Cardiovascular Research·Ahsan A Khan, Gregory Y H Lip
Feb 8, 2019·Cardiovascular & Hematological Disorders Drug Targets·Estefanía Lozano-VelascoDiego Franco
Jun 30, 2019·Frontiers in Genetics·Shengyang JiangBan Liu
Jul 22, 2019·Journal of cardiology·Sumra KomalLi-Rong Zhang
Sep 10, 2019·Thrombosis and Haemostasis·María Asunción Esteve-PastorFrancisco Marín
Dec 6, 2019·Thrombosis and Haemostasis·José Miguel Rivera-Caravaca, María Asunción Esteve-Pastor
Mar 12, 2020·Scientific Reports·Marek KiliszekAndrzej Skrobowski
Apr 8, 2020·Mediators of Inflammation·Xiaona XuGuangping Li
Apr 15, 2020·Advances in Experimental Medicine and Biology·Diego FrancoJorge N Dominguez
May 6, 2020·The Journal of International Medical Research·Yingyuan LiZhongxing Wang
May 21, 2020·Cells·Ying Wang, Bin Liu

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR

Software Mentioned

MedCalc
survIDINRI R
SPSS

Related Concepts

Related Feeds

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Atrial Filbrillation

Atrial fibrillation refers to the abnormal heart rhythm characterized by rapid and irregular beating of the atria. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.